Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1996-9-10
pubmed:abstractText
Eighteen patients with Alzheimer's disease were studied with positron emission tomographic measurements of regional cerebral metabolism of glucose. All patients were initially diagnosed and evaluated, underwent positron emission tomography, and then were followed with annual reevaluations, at which time the Mini-Mental State Examination (MMSE) was performed. Patients were followed for an average of 2.5 years, and the rate of cognitive decline was calculated by determining the rate of change in the MMSE score defined as the MMSE score at the initial evaluation minus the MMSE score at the last examination, divided by the number of months between testing. The regional cerebral metabolic rates for glucose determined at the time of the first MMSE were then regressed on these changes in scores. Results showed that glucose metabolic rates in posterior temporal and primary visual cortex regions were significantly correlated with the subsequent rate of cognitive deterioration. These associations were not confounded by age, length of follow-up, baseline MMSE score, or education. Stratification on gender suggested that these associations were much stronger in women than in men. These results replicate previous findings showing that functional brain imaging is predictive of the rate of cognitive decline in Alzheimer's disease.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/AG07793, http://linkedlifedata.com/resource/pubmed/grant/AG10129, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-03, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-03S1, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-04, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-05, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-06, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-06S1, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-07A2, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-08, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-09, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-10, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-11, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-12A2, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-13, http://linkedlifedata.com/resource/pubmed/grant/R01 AG012975-14, http://linkedlifedata.com/resource/pubmed/grant/R01 DK060753-01, http://linkedlifedata.com/resource/pubmed/grant/R01 DK060753-02, http://linkedlifedata.com/resource/pubmed/grant/R01 DK060753-03, http://linkedlifedata.com/resource/pubmed/grant/R03 AG033751-01A2
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1051-2284
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
156-60
pubmed:dateRevised
2011-8-1
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Functional imaging predicts cognitive decline in Alzheimer's disease.
pubmed:affiliation
Department of Neurology, University of California, Davis, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.